Published in Hepatogastroenterology on August 13, 1999
Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review. BMC Pulm Med (2010) 1.00
Improved survival with the patients with variceal bleed. Int J Hepatol (2011) 0.81
Lack of portosystemic bacterial translocation in patients with liver cirrhosis after placement of transjugular shunt. Eur J Clin Microbiol Infect Dis (2003) 0.75
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology (1996) 4.54
The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med (1994) 3.01
Transjugular intrahepatic portosystemic shunting is not superior to endoscopic variceal band ligation for prevention of variceal rebleeding in cirrhotic patients: a randomized, controlled trial. Scand J Gastroenterol (2002) 2.54
The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med (1995) 2.21
A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med (2000) 2.20
Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer (1999) 2.17
Endoscopic diagnosis of acute intestinal GVHD following allogeneic hematopoietic SCT: a retrospective analysis in 175 patients. Bone Marrow Transplant (2011) 1.73
Hepatitis induced by Noni juice from Morinda citrifolia: a rare cause of hepatotoxicity or the tip of the iceberg? Digestion (2006) 1.66
A novel technique for selective NF-kappaB inhibition in Kupffer cells: contrary effects in fulminant hepatitis and ischaemia-reperfusion. Gut (2009) 1.49
Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet (1997) 1.47
Glutathione protects the rat liver against reperfusion injury after hypothermic preservation. Gastroenterology (1999) 1.45
Percutaneous radiofrequency interstitial thermal ablation of small hepatocellular carcinoma. Lancet (1999) 1.43
Genetic and ultrastructural characterization of a European isolate of the fatal endotheliotropic elephant herpesvirus. J Gen Virol (2001) 1.37
The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art. Liver (1998) 1.23
A sphincterotome-based technique for selective transpapillary common bile duct cannulation. Gastrointest Endosc (2000) 1.21
Preservation injury of the liver: mechanisms and novel therapeutic strategies. J Hepatol (2000) 1.19
Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients. Eur J Gastroenterol Hepatol (2001) 1.15
Evidence for down-regulation of beta-2-adrenoceptors in cirrhotic patients with severe ascites. Lancet (1986) 1.11
Ajoene, a compound of garlic, induces apoptosis in human promyeloleukemic cells, accompanied by generation of reactive oxygen species and activation of nuclear factor kappaB. Mol Pharmacol (1998) 1.04
Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection--a single-center analysis including 132 patients. Int J Cancer (1998) 1.03
Prevention of Kupffer cell-induced oxidant injury in rat liver by atrial natriuretic peptide. Am J Physiol (1999) 1.00
Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt. Gut (1999) 1.00
Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine. Hepatology (1999) 1.00
Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis. Effects on renal hemodynamics and atrial natriuretic factor. Gastroenterology (1991) 0.98
A role for chronic hepatitis C virus infection in a patient with cutaneous vasculitis, cryoglobulinemia, and chronic liver disease. Effective therapy with interferon-alpha. Dig Dis Sci (1995) 0.98
Detection of C-type natriuretic peptide (CNP) transcript in the rat heart and immune organs. Endocrinology (1993) 0.97
Budd-Chiari syndrome: technical, hemodynamic, and clinical results of treatment with transjugular intrahepatic portosystemic shunt. Radiology (1995) 0.96
Endothelin-1 and endothelin-3 in cirrhosis: relations to systemic and splanchnic haemodynamics. J Hepatol (1995) 0.96
Noncavernomatous portal vein thrombosis in hepatic cirrhosis: treatment with transjugular intrahepatic portosystemic shunt and local thrombolysis. Radiology (1995) 0.94
Hepatic progenitor populations in embryonic, neonatal, and adult liver. Proc Soc Exp Biol Med (1993) 0.91
Estimated central blood volume in cirrhosis: relationship to sympathetic nervous activity, beta-adrenergic blockade and atrial natriuretic factor. Hepatology (1992) 0.91
Differential gene expression of the three natriuretic peptides and natriuretic peptide receptor subtypes in human liver. Gut (1997) 0.91
Microcirculatory failure after rat liver transplantation is related to Kupffer cell-derived oxidant stress but not involved in early graft dysfunction. Transplantation (2001) 0.90
JNK inhibition sensitises hepatocellular carcinoma cells but not normal hepatocytes to the TNF-related apoptosis-inducing ligand. Gut (2008) 0.89
Tularaemia seroprevalence of captured and wild animals in Germany: the fox (Vulpes vulpes) as a biological indicator. Epidemiol Infect (2012) 0.89
Isolation, identification, and continuous culture of coronary endothelial cells from guinea pig hearts. Eur J Cell Biol (1981) 0.89
How much reduction in portal pressure is necessary to prevent variceal rebleeding? A longitudinal study in 225 patients with transjugular intrahepatic portosystemic shunts. Am J Gastroenterol (2001) 0.89
Increased renal production of C-type natriuretic peptide (CNP) in patients with cirrhosis and functional renal failure. Gut (2000) 0.88
Influence of training volume and acute physical exercise on the homocysteine levels in endurance-trained men: interactions with plasma folate and vitamin B12. Ann Nutr Metab (2003) 0.88
The transjugular stent implantation for the treatment of malignant portal and hepatic vein obstruction in cancer patients. Ann Oncol (1997) 0.88
Atrial natriuretic factor in plasma of patients with arterial hypertension, heart failure or cirrhosis of the liver. J Hypertens Suppl (1986) 0.88
Tumour associated antigens in diagnosis of serous effusions. J Clin Pathol (1988) 0.87
Acute radiation injury of mice and the influence of sudden time shift. Radiat Res (1984) 0.87
Hepato-pulmonary syndrome: successful treatment by transjugular intrahepatic portosystemic stent-shunt (TIPS) J Hepatol (1995) 0.87
[Achilles tendon power Doppler sonography in 953 long distance runners - a cross sectional study]. Ultraschall Med (2010) 0.86
Atrial natriuretic peptide reduces expression of TNF-alpha mRNA during reperfusion of the rat liver upon decreased activation of NF-kappaB and AP-1. J Hepatol (2000) 0.86
[Elephant herpes virus--a problem for breeding and housing of elephants]. Berl Munch Tierarztl Wochenschr (1999) 0.86
Value of ascitic lipids in the differentiation between cirrhotic and malignant ascites. Hepatology (1986) 0.86
PDE-5 inhibitors lower portal and pulmonary pressure in portopulmonary hypertension. Eur Respir J (2007) 0.85
The reducing stent: treatment for transjugular intrahepatic portosystemic shunt-induced refractory hepatic encephalopathy and liver failure. Radiology (1995) 0.85
The effect of endothelin and its antagonist Bosentan on hemodynamics and microvascular exchange in cirrhotic rat liver. J Hepatol (1998) 0.85
Prevention of ischemia/reperfusion injury in the rat liver by atrial natriuretic peptide. Gastroenterology (1994) 0.84
Headspace solid-phase microextraction (SPME) and gas chromatography-mass spectrometry (GC-MS) for the determination of 5alpha-androst-2-en-17-one and -17beta-ol in the female Asian elephant: application for reproductive monitoring and prediction of parturition. J Steroid Biochem Mol Biol (2003) 0.83
Immunoreactive human chorionic gonadotropin and its free beta subunit in serum and ascites of patients with malignant tumors. Cancer Res (1992) 0.82
6-thioguanine--efficacy and safety in chronic active Crohn's disease. Aliment Pharmacol Ther (2003) 0.82
Hepatic blood flow and splanchnic oxygen consumption in patients with liver failure. Effect of high-volume plasmapheresis. Hepatology (1999) 0.82
Transjugular intrahepatic portosystemic shunt for cirrhosis and ascites: Effects in patients with organic or functional renal failure. Scand J Gastroenterol (2000) 0.82
[Recurrent bleeding from colonic varices in portal hypertension. The successful prevention of recurrence by the implantation of a transjugular intrahepatic stent-shunt (TIPS)]. Dtsch Med Wochenschr (1995) 0.82
Correlation of duplex sonography findings and portal pressure in 375 patients with portal hypertension. AJR Am J Roentgenol (1999) 0.81
Regulation of atrial natriuretic factor release in man: effect of water immersion. Klin Wochenschr (1986) 0.81
Plasma atrial natriuretic factor in patients with cirrhosis. N Engl J Med (1985) 0.81
Remission maintenance by tioguanine in chronic active Crohn's disease. Aliment Pharmacol Ther (2003) 0.81
Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis. Hepatogastroenterology (2001) 0.81
Prolonged antagonism of alpha 1-adrenergic vasoconstriction in the rat liver by atrial natriuretic peptide. Gastroenterology (1995) 0.81
The gastrointestinal system--an essential target organ of the athlete's health and physical performance. Exerc Immunol Rev (1999) 0.81
[52-year-old patient with subcutaneous space-occupying lesion in immunosuppression]. Internist (Berl) (2003) 0.81
Tumour size is an important predictor for the outcome after liver transplantation for hepatocellular carcinoma. Eur J Surg Oncol (2005) 0.80
Endothelin and endothelin receptor antagonism in portopulmonary hypertension. Eur J Clin Invest (2006) 0.80
Increased arterial compliance in cirrhosis is related to decreased arterial C-type natriuretic peptide, but not to atrial natriuretic peptide. Scand J Gastroenterol (2003) 0.80
[Successful conservative therapy of hepatorenal syndrome with vasopressin-1-receptor antagonist ornipressin]. Z Gastroenterol (1998) 0.80
Purine metabolism in cultured coronary endothelial cells. Adv Exp Med Biol (1979) 0.80
Plasma endothelin-1 and -3 in cirrhosis: relationship with systemic hemodynamics, renal function and neurohumoral systems. J Hepatol (1996) 0.79
Short-term effects of statin therapy in patients with hyperlipoproteinemia after liver transplantation: results of a randomized cross-over trial. J Hepatol (2001) 0.79
[Sex steroid profiles and ovarian activities of the female panda Yan Yan in the Berlin Zoo]. Berl Munch Tierarztl Wochenschr (1997) 0.78
The actions of human atrial natriuretic factor on hepatic arterial and portal vascular beds of the anaesthetized dog. Br J Pharmacol (1990) 0.78
Application of a multiple-band ligator in active variceal bleeding. Endoscopy (1996) 0.78
Effects of transjugular intrahepatic portosystemic shunt (TIPS) on quantitative liver function tests. Hepatogastroenterology (1999) 0.78
Endothelin-3 like immunoreactivity in plasma of patients with cirrhosis of the liver. Life Sci (1992) 0.78
Effects of the neutral endopeptidase inhibitor thiorphan on cardiovascular and renal function in cirrhotic rats. Br J Pharmacol (2003) 0.78
Serum neutrophil gelatinase-associated lipocalin - a sensitive novel marker of renal impairment in liver cirrhosis? Digestion (2011) 0.78
Disposal of atrial natriuretic factor (ANF99-126) in patients with cirrhosis: effect of beta-adrenergic blockade. Scand J Clin Lab Invest (1993) 0.77
Changes in blood lactate concentrations during different treadmill exercise test protocols. J Sports Med Phys Fitness (2011) 0.77
[Hepatocellular carcinoma: percutaneous ethanol injection/transarterial chemoembolization/radiofrequency thermoablation]. Praxis (Bern 1994) (2000) 0.77
Q-T interval (QT(C)) in patients with cirrhosis: relation to vasoactive peptides and heart rate. Scand J Clin Lab Invest (2007) 0.77
Successful treatment of chronic Budd-Chiari syndrome with a transjugular intrahepatic portosystemic shunt. J Hepatol (2000) 0.77
Elevated arterial compliance in patients with cirrhosis is not related to arterial endothelin-1. Scand J Gastroenterol (2002) 0.77
Multiple liver abscesses caused by Yersinia enterocolitica in a patient receiving long-term transfusion therapy for osteomyelosclerosis. Dig Dis Sci (1997) 0.77
Association between LDL-cholesterol, statin therapy, physical activity and inflammatory markers in patients with stable coronary heart disease. Exerc Immunol Rev (2005) 0.77
[Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage]. Z Gastroenterol (2002) 0.77
Severe veno-occlusive disease after allogeneic bone marrow or peripheral stem cell transplantation--role of transjugular intrahepatic portosystemic shunt (TIPS). Liver (2001) 0.77
Iron overload syndrome in the black rhinoceros (Diceros bicornis): microscopical lesions and comparison with other rhinoceros species. J Comp Pathol (2012) 0.77
Assessment of central blood volume in cirrhosis by radionuclide angiography: what does it really mean? Hepatology (1994) 0.76
[Current status of abdominal pancreatic ultrasound. A retrospective analysis of 585 pancreatic ultrasound examinations]. Med Klin (Munich) (1994) 0.76
Thioguanine-nucleotides do not predict efficacy of tioguanine in Crohn's disease. Aliment Pharmacol Ther (2004) 0.76